These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8145599)
1. The costs of interrupting antihypertensive drug therapy in a Medicaid population. McCombs JS; Nichol MB; Newman CM; Sclar DA Med Care; 1994 Mar; 32(3):214-26. PubMed ID: 8145599 [TBL] [Abstract][Full Text] [Related]
2. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Dickson M; Plauschinat CA Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937 [TBL] [Abstract][Full Text] [Related]
3. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Law MR; Lu CY; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS Clin Ther; 2010 Apr; 32(4):729-41; discussion 716. PubMed ID: 20435243 [TBL] [Abstract][Full Text] [Related]
4. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. Ahluwalia JS; McNagny SE; Rask KJ J Gen Intern Med; 1997 Jan; 12(1):7-14. PubMed ID: 9034941 [TBL] [Abstract][Full Text] [Related]
5. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years. McCombs JS; Luo M; Johnstone BM; Shi L Value Health; 2000; 3(3):222-31. PubMed ID: 16464186 [TBL] [Abstract][Full Text] [Related]
6. Utility of a transdermal delivery system for antihypertensive therapy. Part 1. Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801 [TBL] [Abstract][Full Text] [Related]
7. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. McCombs JS; Nichol MB; Stimmel GL; Sclar DA; Beasley CM; Gross LS J Clin Psychiatry; 1990 Jun; 51 Suppl():60-9; discussion 70-1. PubMed ID: 2189876 [TBL] [Abstract][Full Text] [Related]
8. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. McCombs JS; Ahn J; Tencer T; Shi L J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396 [TBL] [Abstract][Full Text] [Related]
9. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009. Davis-Ajami ML; Wu J; Fink JC Value Health; 2014; 17(1):51-61. PubMed ID: 24438717 [TBL] [Abstract][Full Text] [Related]
10. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program. Hay JW; Leahy M Value Health; 2005; 8(4):506-16. PubMed ID: 16091028 [TBL] [Abstract][Full Text] [Related]
11. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Rizzo JA; Simons WR Clin Ther; 1997; 19(6):1446-57; discussion 1424-5. PubMed ID: 9444452 [TBL] [Abstract][Full Text] [Related]
12. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus. Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736 [TBL] [Abstract][Full Text] [Related]
13. Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization. Skaer TL; Sclar DA; Robison LM; Chin A; Gill MA; Okamoto MP; Nakahiro RK Clin Ther; 1993; 15(4):715-25; discussion 714. PubMed ID: 8221822 [TBL] [Abstract][Full Text] [Related]
14. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study. Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056 [TBL] [Abstract][Full Text] [Related]
15. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. McCombs JS; Nichol MB; Stimmel GL; Shi J; Smith RR J Clin Psychiatry; 1999; 60 Suppl 19():5-11; discussion 12-3. PubMed ID: 10507275 [TBL] [Abstract][Full Text] [Related]
16. Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications. Wilson J; Axelsen K; Tang S Am J Manag Care; 2005 Jan; 11 Spec No():SP27-34. PubMed ID: 15700907 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension. Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135 [TBL] [Abstract][Full Text] [Related]
18. Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives? Ketcham JD; Epstein AJ Pharmacoeconomics; 2006; 24 Suppl 3():27-40. PubMed ID: 17266386 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Baggarly SA; Kemp RJ; Wang X; Magoun AD Res Social Adm Pharm; 2014; 10(6):e99-e112. PubMed ID: 24731547 [TBL] [Abstract][Full Text] [Related]
20. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Khanna R; Smith MJ Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]